CVE-2026-52866
6.5
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Summary
An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Affected Software
| Vendor | Product | Version Range | Status |
|---|---|---|---|
| Apollo Pharmacy | Blood Glucose Monitoring System (Model No. APG-01 BT) | 0x0110_v1.1.0 | affected |
Weaknesses
- CWE-862: CWE-862
Workarounds
Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information: https://www.apollopharmacy.in/contact-us
CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog: https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
ADP Enrichment
CISA ADP Vulnrichment
- SSVC:
- Exploitation: none
- Automatable: no
- Technical Impact: partial
References
- https://www.apollopharmacy.in/contact-us
- https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json
Feedback
Was this page helpful?
Glad to hear it! Please tell us how we can improve.
Sorry to hear that. Please tell us how we can improve.